KOCHI: Perumbavoor, long known as Kerala’s plywood hub, is scripting an unlikely new chapter — one written not in sawdust, but in silicon. On February 11, the land that once hosted Travancore Rayons, ...
MYSURU: After remaining on paper for nearly a decade, the proposed Mysuru Film City project — a major infrastructure initiative of the Karnataka government aime ...
The horror film draws from the authentic account of the aforementioned killers, who murdered no fewer than 16 individuals in 1828 Edinburgh, selling their remains for anatomical investigation. The ...
The selloff deepened, and the Dow Jones ( DJI) shed 1,200 points — on pace for its worst drop since Liberation Day — while ...
Duke of Sussex calls for aid corridors to be opened in Gaza - The Duke and Duchess of Sussex are visiting Jordan.
Excellencies, Honourable Ministers, Industry Leaders, Innovators, Entrepreneurs, Researchers, Delegates, distinguished guests, ladies and gentlemen – Namaste! A heartfelt welcome to all of you at the ...
Morning Overview on MSN
Comet 3I/ATLAS bolts away but its late eruptions just rewrote science
Comet 3I/ATLAS is already racing back into deep space, but its surprise resurgence in December 2025 has turned a fading curiosity into a case that planetary scientists will be arguing over for years.
In our ongoing CEO diaries, we hear from Christoph Bang, one of three managing directors of BANG Kransysteme to find out what ...
Opinion: A settlement agreement between and Federal Trade commission and Express Scripts may prove more transformative than any single pricing overhaul because it has restructured the rebate-driven ...
The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...
Express Scripts, a pharmacy benefit manager and subsidiary of Cigna (CI), has reached a settlement with the FTC over accusations that it artificially inflated the prices of insulin drugs, violating ...
The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results